The Proliferation REduction with Vascular ENergy Trial (PREVENT)
PREVENT was the first prospective, randomized placebo-controlled study of intracoronary beta radiotherapy with (32)P. A total of 105 patients with de novo or restenotic lesions, treated by stenting or balloon angioplasty, received 0 (control), 16, 20, or 24 Gy to a depth of 1 mm beyond the lumen sur...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59647/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806768/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-1-016 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|